- •
Atherosclerotic lower extremity peripheral arterial disease (PAD) is a highly prevalent condition associated with a significant increase in risk of all-cause mortality and cardiovascular morbidity and mortality.
- •
PAD is underdiagnosed and undertreated.
- •
Treatment is focused on 2 primary objectives: (1) lowering cardiovascular risk and cardiovascular disease (CVD) event rates and (2) improvement in symptoms and quality of life.
- •
Contemporary multidisciplinary and intersociety guidelines exist to
Contemporary and Optimal Medical Management of Peripheral Arterial Disease
Section snippets
Key points
Background
PAD refers to the stenosis, occlusion, or aneurysmal change of upper extremity and/or lower extremity arteries.1, 2 Although the term, PAD, can be used to categorize a variety of disease entities and presentations, the acute and chronic conditions associated with atherosclerosis are the most common. The focus of this review is on the epidemiology, risk factors, and medical management of nonacute atherosclerotic lower extremity PAD.
Epidemiology
PAD affects more than 8 million adults in the United States alone.3 PAD is a disease of aging, with an increase in disease prevalence from 10% in individuals aged 65 to more than 30% in octogenarians.4, 5 Concomitant PAD is highly prevalent in individuals with new or established cerebrovascular or coronary artery disease, with prevalence rates greater than 30%.6, 7 Many studies have demonstrated equal prevalence among genders but there is a well-described ethnic disparity, with PAD afflicting
Pathophysiology
Claudication symptoms occur due to a mismatch in oxygen demand and delivery in the skeletal muscles. Arterial insufficiency and PAD most often occur due to insidious progression in the severity of atherosclerosis, but other processes can also cause reduced arterial blood flow (Box 1). The presence and severity of symptoms are also affected by other physiologic factors (muscle mechanics and energy metabolism, endothelial function, collateral blood flow, oxygen delivery, and carrying capacity)
Screening and diagnosis
Given the frequency of asymptomatic and atypical presentations of PAD, with the low sensitivity of disease detection by history alone, accurate diagnosis hinges on effective screening of patients at risk for PAD. Patients considered at high risk for PAD and who should be considered for screening include1, 16
- •
People under age 50 with diabetes and 1 additional atherosclerotic risk factor
- •
People aged 50 and older with diabetes and/or smoking history
- •
Anyone greater than 65 years of age
- •
Those with known
Risk factors
The risk factors for atherosclerotic PAD are similar to the risk factors that promote atherosclerotic changes in other arterial vascular beds, with differences in the magnitude of risk conferred by each risk factor on PAD development.
Medical treatment
Complete recommendations for the optimal medical management of patients with PAD are in the recently published and updated American College of Cardiology Foundation/American Heart Association (ACCF/AHA) task force guidelines on the management of patients with PAD, which were developed in collaboration with the Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society for Vascular Medicine, and Society for Vascular Surgery.1, 16 According to these
Summary
PAD is an underdiagnosed and undertreated condition that is associated with a considerable increase in morbidity and mortality. Patients with PAD, regardless of symptom status, are at high risk of future cardiovascular events and mortality and require aggressive medical intervention and education. This is not always achieved in the primary care setting. Unfortunately, by the time PAD is diagnosed, the deleterious effects and risks associated with the condition have become well established.
References (89)
- et al.
Low ankle-brachial index predicts an adverse 1-year outcome after acute coronary and cerebrovascular events
J Thromb Haemost
(2006) - et al.
The effect of novel cardiovascular risk factors on the ethnic-specific odds for peripheral arterial disease in the Multi-Ethnic Study of Atherosclerosis (MESA)
J Am Coll Cardiol
(2006) - et al.
Risk of mortality and cardiovascular disease associated with the ankle-brachial index: systematic review
Atherosclerosis
(2006) - et al.
2011 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Peripheral Artery Disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
J Am Coll Cardiol
(2011) The peripheral vascular consequences of smoking
Ann Vasc Surg
(1991)- et al.
Serum high-density lipoproteins in peripheral vascular disease
Lancet
(1978) - et al.
Effectiveness of a smoking cessation program for peripheral artery disease patients: a randomized controlled trial
J Am Coll Cardiol
(2010) - et al.
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial
Lancet
(2005) - et al.
Atherosclerotic risk factor control in patients with peripheral arterial disease
J Vasc Surg
(2005) - et al.
Baseline functional performance predicts the rate of mobility loss in persons with peripheral arterial disease
J Am Coll Cardiol
(2007)
Supervised exercise therapy for intermittent claudication in a community-based setting is as effective as clinic-based
J Vasc Surg
ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation
Circulation
Atherosclerotic Peripheral Vascular Disease Symposium II: nomenclature for vascular diseases
Circulation
Heart disease and stroke statistics—2012 update: a report from the American Heart Association
Circulation
Prevalence of peripheral arterial disease and risk factors in persons aged 60 and older: data from the National Health and Nutrition Examination Survey 1999-2004
J Am Geriatr Soc
Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group
Circulation
Low ankle-brachial index predicts cardiovascular risk after acute ischemic stroke or transient ischemic attack
Stroke
Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis
JAMA
Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: the Strong Heart Study
Circulation
The diagnosis of ischaemic heart pain and intermittent claudication in field surveys
Bull World Health Organ
Peripheral arterial disease detection, awareness, and treatment in primary care
JAMA
Mortality and vascular morbidity in older adults with asymptomatic versus symptomatic peripheral artery disease
Circulation
Asymptomatic peripheral arterial disease is associated with more adverse lower extremity characteristics than intermittent claudication
Circulation
The magnitude of the problem of peripheral arterial disease: epidemiology and clinical significance
Cleve Clin J Med
Measurement and Interpretation of the Ankle-Brachial Index: a Scientific Statement From the American Heart Association
Circulation
The measurement of atherosclerotic peripheral arterial disease in epidemiological surveys
Int J Epidemiol
Screening for peripheral arterial disease: the sensitivity, specificity, and predictive value of noninvasive tests in a defined population
Am J Epidemiol
Smoking, lipids, glucose intolerance, and blood pressure as risk factors for peripheral atherosclerosis compared with ischemic heart disease in the Edinburgh Artery Study
Am J Epidemiol
Relationship between smoking and cardiovascular risk factors in the development of peripheral arterial disease and coronary artery disease: Edinburgh Artery Study
Eur Heart J
Epidemiology, classification, and modifiable risk factors of peripheral arterial disease
Vasc Health Risk Manag
Pathophysiology of peripheral arterial disease and risk factors for its development
Cleve Clin J Med
Cessation of smoking in patients with intermittent claudication. Effects on the risk of peripheral vascular complications, myocardial infarction and mortality
Acta Med Scand
Passive smoking and risk of peripheral arterial disease and ischemic stroke in Chinese women who never smoked
Circulation
Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus
Ann Intern Med
Peripheral arterial disease in diabetic and nondiabetic patients: a comparison of severity and outcome
Diabetes Care
Peripheral arterial disease in people with diabetes
Diabetes Care
Update on some epidemiologic features of intermittent claudication: the Framingham Study
J Am Geriatr Soc
Hypertension and peripheral arterial disease
Vasc Med
Mortality over four years in SHEP participants with a low ankle-arm index
J Am Geriatr Soc
Plasma lipids as a risk factor in peripheral vascular disease
Angiology
Associations between conventional cardiovascular risk factors and risk of peripheral artery disease in men
JAMA
A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes
JAMA
Prospective blinded study of the relationship between plasma homocysteine and progression of symptomatic peripheral arterial disease
J Vasc Surg
Homocysteine lowering with folic acid and B vitamins in vascular disease
N Engl J Med
Cited by (5)
Safety and efficacy of cell-based therapy on critical limb ischemia: A meta-analysis
2016, CytotherapyCitation Excerpt :CLI is associated with atherosclerosis, diabetes and thrombus occlusive vasculitis. The etiology of atherosclerosis is unclear; one epidemiological study found that 15%–20% of atherosclerosis patients who display symptoms will develop severe limb ischemia [4,5]. Diabetic limb ischemia often occurs with multiple arterial occlusions making revascularization difficult and complex [6].
Gene Therapy for the Prevention of Vein Graft Disease
2015, Translating Gene Therapy to the Clinic: Techniques and ApproachesPerioperative management of lower extremity revascularization
2014, Anesthesiology ClinicsCitation Excerpt :Smoking is the most powerful risk factor for the development of PAD and many patients have concomitant chronic obstructive lung disease. Smokers with PAD experience worse disease-specific outcomes, with higher rates of CLI and amputation, higher procedural complications, and increased risk of graft failure.15 As with most surgical procedures, the choice of monitors is heavily influenced by anesthetic technique, surgical plan, and patient comorbidities.
Statin use is associated with improved overall survival without affecting patency and limb salvage rates following open or endovascular revascularization
2014, Vascular Medicine (United Kingdom)